{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:27Z","timestamp":1790516187229,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.maturitas.2018.01.012","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T21:55:05Z","timestamp":1515794105000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy"],"prefix":"10.1016","volume":"111","author":[{"given":"A.","family":"Stuursma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.G.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"Wessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.E.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2018.01.012_bib0005","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0010","series-title":"SEER Stat Fact Sheets: Ovarian Cancer","year":"2016"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2005.08.038","article-title":"CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer","volume":"100","author":"Olivier","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","article-title":"Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers?","volume":"124","author":"van der Velde","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0035","series-title":"Oncoline -Landelijke richtlijn erfelijk en familiair ovariumcarcinoom","year":"2017"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1021119405814","article-title":"Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer","volume":"1","author":"Elit","year":"2001","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.maturitas.2011.08.001","article-title":"Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: a review","volume":"70","author":"Finch","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0055","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1365.032","article-title":"Hormone replacement therapy in breast cancer survivors","volume":"1092","author":"Xydakis","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10689-012-9527-5","article-title":"The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause","volume":"11","author":"Pezaro","year":"2012","journal-title":"Fam. Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2018.01.012_bib0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-008-0138-7","article-title":"Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study","volume":"115","author":"Buijs","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2011.10.008","article-title":"Model of care for women at increased risk of breast and ovarian cancer","volume":"71","author":"De Bock","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/13697130009167600","article-title":"The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints","volume":"3","author":"Schneider","year":"2000","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1477-7525-2-45","article-title":"The menopause rating scale (MRS) scale: a methodological review","volume":"2","author":"Heinemann","year":"2004","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0090","unstructured":"Ministerie van sociale zaken en werkgelegenheid. Nederlandse Norm Gezond Bewegen (NNGB). https:\/\/www.arboportaal.nl\/externe-bronnen\/inhoud\/overige-nuttige-links\/nederlandse-norm-gezond-bewegen-nngb. 2000, (Accessed 17 January 2017)."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0095","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1249\/mss.0b013e3180616b27","article-title":"Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association","volume":"39","author":"Haskell","year":"2007","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13697130802585576","article-title":"Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview","volume":"12","author":"Al-Baghdadi","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/07399332.2011.646374","article-title":"Symptoms experienced by women who enter into natural and surgical menopause and their relation to sexual functions","volume":"33","author":"Topatan","year":"2012","journal-title":"Health Care Women Int."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5122(97)00047-9","article-title":"A study of European womens\u2019 experience of the problems of urogenital ageing and its management","volume":"27","author":"Barlow","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0115","first-page":"351","article-title":"A prospective population-based study of menopausal symptoms","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0120","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0277-9536(01)00326-4","article-title":"Change in psychological and vasomotor symptom reporting during the menopause","volume":"55","author":"Hardy","year":"2002","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00005053-199911000-00006","article-title":"Mood and the menopausal transition","volume":"187","author":"Dennerstein","year":"1999","journal-title":"J. Nerv. Ment. Dis."},{"issue":"3","key":"10.1016\/j.maturitas.2018.01.012_bib0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00006842-199005000-00009","article-title":"Psychological and somatic experience of the menopause: a prospective study [corrected]","volume":"52","author":"Hunter","year":"1990","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/13697130902780846","article-title":"Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy","volume":"12","author":"Benshushan","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5122(95)00970-1","article-title":"Well-being, symptoms and the menopausal transition","volume":"23","author":"Dennerstein","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2015.12.004","article-title":"The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy","volume":"85","author":"Tucker","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ctrv.2008.04.001","article-title":"The influence of endocrine treatments for breast cancer on health-related quality of life","volume":"34","author":"Buijs","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.maturitas.2018.01.012_bib0155","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/pon.3772","article-title":"Risk factors for negative impacts on sexual activity and function in younger breast cancer survivors","volume":"24","author":"Lee","year":"2015","journal-title":"Psychooncology"},{"key":"10.1016\/j.maturitas.2018.01.012_bib0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-12-26","article-title":"Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review","volume":"12","author":"Peign\u00e9","year":"2014","journal-title":"Reprod. Biol. Endocrinol."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217309507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217309507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:12:00Z","timestamp":1759914720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512217309507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":32,"alternative-id":["S0378512217309507"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.01.012","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}